Efficacy of an anti-properdin MoAb in two models of complement-mediated tissue in jury

Author： Parent J.B.   Benzing W.C.   Gupta-Bansal R.   Convery M.   Anderson R.   Brunden K.R.  

Publisher： Elsevier

ISSN： 0162-3109

Source： Immunopharmacology, Vol.49, Iss.1, 2000-08, pp. : 68-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Properdin and Complement Activation: A Fresh Perspective

By  

Current Drug Targets, Vol. 9, Iss. 2, 2008-02 ,pp. : 158-164

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Complement Properdin in Renal Ischemia-Reperfusion Injury

By  

Current Gene Therapy, Vol. 17, Iss. 6, 2018-03 ,pp. : 411-423

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of neutrophil elastase activity attenuates complement-mediated lung injury in the hamster

By Hagio T.   Nakao S.   Matsuoka H.   Matsumoto S.   Kawabata K.   Ohno H.  

European Journal of Pharmacology, Vol. 426, Iss. 1, 2001-08 ,pp. : 131-138

Elsevier

Access to resources Recommend Favorite

Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics

By Sahu  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 133-148

Elsevier

Access to resources Recommend Favorite

The Possibilities and Pitfalls for Anti-Complement Therapies in Inflammatory Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 1, 2004-03 ,pp. : 87-96

Bentham Science Publishers

Access to resources Recommend Favorite